Delivery Order SPE2DR25D3005-SPE2DR26FP8VH
Award Date 1/22/26
Potential Completion Date 1/23/26
Potential Value $37K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $94,718.38 on January 14, 2026, for the supply of Gemtesa 75 mg tablets (90-count packages). This competitively awarded, firm fixed-price contract carries an ultimate completion date of January 15, 2026, and represents a non-set-aside procurement. The award was issued by the Defense Logistics Agency, which oversees medical supply procurement for...
- The Defense Logistics Agency awarded a delivery order valued at $1,529.94 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units) on January 22, 2026, with an ultimate completion date of January 23, 2026. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $20,765.70 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price, non-set-aside contract is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc.'s...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Gemtesa 75 mg tablets (90-count units) with a ceiling value of $16,491.74. This firm fixed-price delivery order, which is due for completion by July 22, 2025, represents a pharmaceutical supply requirement under DLA's medical procurement operations. The award was competitively awarded with no set-aside designation, and AmerisourceBergen will perform the work at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for supply of Gemtesa 75 mg tablets (90-count packages) valued at $17,378.99. This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of January 22, 2026. The delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Gemtesa 75 mg tablets (90-count packaging) with a ceiling value of $6,885.96 under a firm fixed-price contract. This delivery order represents a non-set-aside competitive award, indicating the contract was competed on a full and open basis. The work is to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Gemtesa 75 mg tablets (90-count units) with a ceiling value of $15,355.05. This firm fixed-price, competitive delivery order represents performance through January 15, 2026, and carries no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal military and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $57,339.96 on September 5, 2025, for the supply of Gemtesa 75 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by September 8, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for $10,324.10 on January 6, 2026, with an ultimate completion date of January 7, 2026. The contract covers the supply of Gemtesa 75 mg tablets in quantities of 90 units and employs firm fixed-price pricing. This non-set-aside award was competitively awarded and serves the federal government's pharmaceutical procurement needs,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $27,590.20 by the Defense Logistics Agency on December 3, 2025, for the supply of Gemtesa 75 mg tablets (90-count). This firm fixed-price, non-set-aside contract is scheduled for completion by December 4, 2025, with performance taking place at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under a larger contract...